BIOCRYST PHARMACEUTICALS INC 4

Director Amy E. McKee received 644 shares of Biocryst Pharmaceuticals, Inc. common stock as a board retainer stock award valued at about $6.2K.

On August 31, 2026, director Amy E. McKee received 644 shares of Biocryst Pharmaceuticals, Inc. common stock at an implied price of $9.70 per share, issued in lieu of 50% of her $12,500 quarterly cash board retainer, resulting in an award valued at approximately $6,247 and bringing her direct holdings to 47,821 shares. This appears to be a routine equity compensation transaction rather than an open-market trade.

Filing Facts

CIK

882796

Ticker

BCRX

Form

4

Source Type

fda

Accession

0000882796-26-000059

Alert Tier

4